S. Mes
发表
E. Dronkers,
R. J. Baatenburg de Jong,
M. Wieringa,
2015,
BMC Cancer.
C. R. Leemans,
E. Sistermans,
R. Brakenhoff,
2020,
Oral oncology.
R. Boellaard,
C. R. Leemans,
M. A. van de Wiel,
2020,
European Radiology.
C. R. Leemans,
E. Bloemena,
R. Brakenhoff,
2019,
The Journal of molecular diagnostics : JMD.
Multiple sclerosis-associated CLEC16A controls HLA class II expression via late endosome biogenesis.
J. Neefjes,
R. Hintzen,
J. Laman,
2015,
Brain : a journal of neurology.
C. R. Leemans,
M. A. van de Wiel,
T. Poli,
2019,
Clinical Cancer Research.
C. R. Leemans,
R. Brakenhoff,
S. Mes,
2016,
Expert review of molecular diagnostics.
S. Mes,
J. Quak,
P. Borggreven,
2022,
European Archives of Oto-Rhino-Laryngology.
S. Mes,
J. Quak,
P. Borggreven,
2022,
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.
Ruud H. Brakenhoff,
Elisabeth Bloemena,
Mark A. van de Wiel,
2017,
Oncotarget.
Ruud H. Brakenhoff,
Mark A. van de Wiel,
Saskia M. Wilting,
2017,
BMC Bioinformatics.
M. Steenwijk,
P. de Graaf,
C. Leemans,
2022,
Cancer Imaging.
R. Boellaard,
M. A. van de Wiel,
P. de Graaf,
2023,
Oral oncology.
E. Dronkers,
R. J. Baatenburg de Jong,
M. Wieringa,
2015,
BMC Cancer.
Floris H. P. van Velden,
Ronald Boellaard,
Mark A. van de Wiel,
2019,
ArXiv.